Transforming Kidney Health with Science & Innovation

Discover Pro24c, an advanced citrate formula designed to restore acid-base balance, support kidney function, and enhance metabolic health—backed by clinical research for long-term well-being.

About Us

Prosalix is a Swiss pharmaceutical startup headquartered in Basel, Switzerland.The company is developing Pro24c, a medicinal product to treat acid-base imbalances and to reduce associated long-term risks. Compared to current treatment opportunities Pro24c will significantly improve the medium and long-term quality of life for patients

Short profile…

Products

Our Solution – Pro24c

Treatment of diseases in nephrology, urology and endocrinology

An innovative prescription medication in the form of stickpacks, containing citrates, is dispensed to patients in a patient-friendly dosage form with water-soluble properties and a neutral taste.

How Pro24c works

Potassium citrate Magnesium citrate

An imbalance in the acid-base regulation can cause various health problems.

The 4 indications

Encrustation of bladder catheters

Kidney stones

Hyperacidity of the blood in chronic renal insufficiency

Encrustation of bladder catheters

Cause

Change in the urine environment

Primary kidney stones (cured) Western diet, supersaturation of urine with oxalate

Renal dysfunction with a decrease in the glomerular filtration rate

Obesity, lack of exercise, Western diet

Consequences

Infections, blockages, reflux, bladder stones

Infections, blockages, reflux, bladder stones

Decrease of bicarbonate in the blood -> dialysis, kidney transplantation

Insulin resistance, type 2 diabetes

Pro24c

Reduction of encrustation and complications

Increase the citrate level in the urine, prevention of secondary kidney stones

Slowing the progression of CKD

Decrease in insulin resistance, Reduction of the risk of diabetes, Prevention of cardiovascular risks

Indications

Incomplete distal renal-tubular acidosis (i-dRTA)

A group of disorders in which the excretion of hydrogen ions (H+) and/or the reabsorption of bicarbonate (HCO3-) in the kidneys is impaired, are identified as renal-tubular acidoses. The mentioned disease i-dRTA can be inherited or later on in the life be acquired. The urine shows an abnormal acidic value, do to a underexcretion of hydrogen ions (pH > 5.5). To compensate for this negative effect, the organism uses the blood buffer system, i.e. by shifting electrolytes between blood and urine. The chronic process is associated frequently with complications of kidney calcification or a formation of kidney stones. Furthermore, the bone microarchitecture is deteriorated in the long term due to the net loss of calcium. It is known from the literature that a reasonable proportion of patients with kidney stones or osteoporosis have this underlying disease.

cONTSCT US

Sebastian Wowra

Member of the Board